Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-16009333Phase 4Completed
Phase 4 trial of hetastarch in brain neoplasm (2 arms), sponsored by Xinhua Hospital. Primary endpoint: Thromboelastography parameters. Started Feb 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-16009333.